Corbus Pharmaceuticals
CRBP
CRBP
88 hedge funds and large institutions have $150M invested in Corbus Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.27% more ownership
Funds ownership: 1.01% → 1.28% (+0.27%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
81% less call options, than puts
Call options by funds: $263K | Put options by funds: $1.4M
Holders
88
Holding in Top 10
1
Calls
$263K
Puts
$1.4M
Top Buyers
| 1 | +$9.58M | |
| 2 | +$7.08M | |
| 3 | +$4.69M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.26M |
| 5 |
Morgan Stanley
New York
|
+$3.29M |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$1.52M | |
| 3 | -$354K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$243K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$179K |